Windtree Therapeutics, Inc., A Biotechnology Company Focused On Advancing Multiple Late-Stage Interventions For Acute Cardiovascular Disorders, Today Announced It Has Entered Into A Global Licensing Agreement With Lee
Found this useful? Share it with your team.
